Immunotherapy Drug Improves Overall Survival in Patients With Cervical Cancer – Curetoday.com
Curetoday.com |
Immunotherapy Drug Improves Overall Survival in Patients With Cervical Cancer
Curetoday.com An immunotherapy targeting human papillomavirus (HPV)-infected cells led to an unprecedented one-year survival rate in patients with recurrent metastatic cervical cancer, according to a phase II study reported at the 2017 Society of Gynecology Oncology … |
